CoraLite® Plus 488-conjugated Prostein Monoclonal antibody

Prostein Monoclonal Antibody for IF-P

Host / Isotype

Mouse / IgG2b

Reactivity

human

Applications

IF-P

Conjugate

CoraLite® Plus 488 Fluorescent Dye

CloneNo.

5E12E2

Cat no : CL488-60343

Synonyms

IPCA 2, IPCA 6, IPCA 8, IPCA6, PCANAP2, PCANAP6, PCANAP8, Prostein, PRST, SLC45A3

---

Validation Data Gallery

• 

  IF Staining of human prostate cancer using CL488-60343

  Immunofluorescent analysis of (4% PFA) fixed human prostate cancer tissue using CoraLite® Plus 488 Prostein antibody (CL488-60343, Clone: 5E12E2 ) at dilution of 1:200.

---

Tested Applications

• Positive IF-P detected in: human prostate cancer tissue

Recommended dilution

• Immunofluorescence (IF)-P: IF-P : 1:50-1:500

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, Check data in validation data gallery.

Product Information

CL488-60343 targets Prostein in IF-P applications and shows reactivity with human samples.

• Tested Reactivity: human
• Host / Isotype: Mouse / IgG2b
• Class: Monoclonal
• Type: Antibody
• Immunogen: Prostein fusion protein Ag5463
• Full Name: solute carrier family 45, member 3
• Calculated Molecular Weight: 59 kDa
• Observed Molecular Weight: 55-59 kDa
• GenBank Accession Number: BC050416
• Gene Symbol: Prostein
• Gene ID (NCBI): 85414
• RRID: AB_2919250
• Conjugate: CoraLite® Plus 488 Fluorescent Dye
• Excitation/Emission Maxima Wavelengths: 493 nm / 522 nm
• Form: Liquid
• Purification Method: Protein A purification
• Storage Buffer: PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
• Storage Conditions: Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20^oC storage.

Background Information

Prostein is a prostate tissue-specific protein whose expression is highly restricted to normal and cancerous prostate tissues. Anti-prostein is useful for the identification of prostate adenocarcinomas and is a good marker to identify prostatic origin in metastatic cancer.